Detalhe da pesquisa
1.
Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cells.
Proc Natl Acad Sci U S A
; 120(19): e2300706120, 2023 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37126700
2.
Clinical and Prognostic Biomarker Value of Blood-Circulating Inflammatory Cytokines in Hepatocellular Carcinoma.
Oncology
; 101(11): 730-737, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37467732
3.
Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma.
J Hepatocell Carcinoma
; 11: 455-461, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38463542
4.
A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinoma.
JHEP Rep
; 6(2): 100982, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38274490
5.
Systemic Neoadjuvant and Adjuvant Therapies in the Management of Hepatocellular Carcinoma-A Narrative Review.
Cancers (Basel)
; 15(13)2023 Jul 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37444618
6.
Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cells.
bioRxiv
; 2023 Mar 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36945365
7.
The Gut Microbiome as a Biomarker and Therapeutic Target in Hepatocellular Carcinoma.
Cancers (Basel)
; 15(19)2023 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37835569
8.
Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study.
Hepatol Commun
; 7(11)2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37889520
9.
Mycobacterium ulcerans lung infection in an immunocompetent patient.
BMJ Case Rep
; 15(8)2022 08 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35944937
10.
Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients.
Oncotarget
; 13: 1314-1321, 2022 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36473155